2024
P10.25.A STANDARDIZATION AND AUTOMATIZATION OF MEASURING AND REPORTING BRAIN METASTASIS OVER TIME BY LEVERAGING ARTIFICIAL INTELLIGENCE
Weiss D, Bousabarah K, Deuschl C, Chadha S, Ashraf N, Ramakrishnan D, Moawad A, Osenberg K, Schoenherr S, Lautenschlager J, Holler W, Westerhoff M, Schrickel E, Memon F, Moily N, Malhotra A, Lin M, Aboian M. P10.25.A STANDARDIZATION AND AUTOMATIZATION OF MEASURING AND REPORTING BRAIN METASTASIS OVER TIME BY LEVERAGING ARTIFICIAL INTELLIGENCE. Neuro-Oncology 2024, 26: v61-v61. PMCID: PMC11485790, DOI: 10.1093/neuonc/noae144.201.Peer-Reviewed Original ResearchReports of brain metastasesBrain metastasesInter-observer variabilityFollow-up imaging of patientsPost-Gamma knife radiosurgeryBrain tumorsRANO-BM criteriaFollow-up imagingBoard-certified neuroradiologistsTreatment response monitoringMean Dice coefficientImages of patientsNnU-Net segmentationManual diameter measurementsBM evaluationRANO-BMRetrospective studyTreatment regimenSpearman correlation coefficientInter-rater variabilityMRI reportsIdentified lesionsPercentual changePost-gammaNeuroradiologists
2022
Deciphering the Clinical Trials of Immunotherapy in Glioblastoma: What a Neuroradiologist Needs to Know
Varzaneh F, Merkaj S, Petersen G, Bahar R, Jekel L, Pala A, Malhotra A, Ivanidze J, Aboian M. Deciphering the Clinical Trials of Immunotherapy in Glioblastoma: What a Neuroradiologist Needs to Know. Neurographics 2022, 12: 176-187. DOI: 10.3174/ng.2100055.Peer-Reviewed Original ResearchTreatment of glioblastomaClinical trialsTrial failuresImmune checkpoint inhibitorsMechanisms of immunotherapyPrimary intracranial neoplasmsCheckpoint inhibitorsSurgical resectionImmunotherapeutic approachesSurvival outcomesIntracranial neoplasmsRadiation therapyImmunotherapyGlioblastoma treatmentGlioblastomaMultidisciplinary approachTrialsTreatmentNeuroradiologistsPresent studyFuture directionsResectionChemotherapyFailurePrognosis